Caris Life Sciences (CAI) Enterprise Value (2024 - 2026)

Caris Life Sciences' Enterprise Value history runs 3 years deep, the most recent figure standing at -$823.5 million for Q1 2026.

• On a quarterly basis, Enterprise Value changed N/A year-over-year to -$823.5 million in Q1 2026; TTM through Mar 2026 was -$823.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$800.1 million, down 1082.82% from the prior year.
• Enterprise Value declined to -$823.5 million in Q1 2026 per CAI's latest filing, from -$800.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$67.6 million in Q4 2024 and bottomed at -$823.5 million in Q1 2026.
• The 3-year median for Enterprise Value is -$757.0 million (2025), against an average of -$634.0 million.
• Biggest YoY gain for Enterprise Value was 1082.82% in 2025; the steepest drop was 1082.82% in 2025.
• Year by year, Enterprise Value stood at -$67.6 million in 2024, then plunged by 1082.82% to -$800.1 million in 2025, then slipped by 2.92% to -$823.5 million in 2026.
• Per Business Quant, the three latest CAI Enterprise Value figures stand at -$823.5 million (Q1 2026), -$800.1 million (Q4 2025), and -$757.0 million (Q3 2025).